ANI Pharmaceuticals
ANIP
#4792
Rank
โ‚น124.44 B
Marketcap
โ‚น5,718
Share price
-0.98%
Change (1 day)
1.05%
Change (1 year)

Revenue for ANI Pharmaceuticals (ANIP)

Revenue in 2024 (TTM): โ‚น51.73 Billion

According to ANI Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚น52.47 Billion. an increase over the revenue in the year 2023 that were of โ‚น40.52 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ANI Pharmaceuticals from 2000 to 2024

Annual revenue

Year Revenue Change
2024 โ‚น52.70 B30.05%
2023 โ‚น40.52 B54.8%
2022 โ‚น26.18 B62.74%
2021 โ‚น16.08 B5.51%
2020 โ‚น15.24 B3.51%
2019 โ‚น14.72 B4.5%
2018 โ‚น14.09 B24.83%
2017 โ‚น11.29 B29.19%
2016 โ‚น8.74 B72.33%
2015 โ‚น5.07 B42.98%
2014 โ‚น3.54 B132.79%
2013 โ‚น1.52 B1109.65%
2012 โ‚น0.12 B447.23%
2011 โ‚น23.01 M-79.24%
2010 โ‚น0.11 B89.93%
2009 โ‚น58.37 M-67.73%
2008 โ‚น0.18 B834.83%
2007 โ‚น19.34 M-96.97%
2006 โ‚น0.63 B5400.6%
2005 โ‚น11.62 M244.66%
2004 โ‚น3.37 M
2001 โ‚น86.76 M2922.57%
2000 โ‚น2.87 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น347.54 B 562.29%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
โ‚น0.73 B-98.60%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.413 T 2,592.65%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
โ‚น5.434 T 10,256.20%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น26.53 B-49.43%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น0.59 B-98.86%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น18.975 T 36,060.27%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.417 T 8,318.62%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚น193.34 B 268.43%๐Ÿ‡ฌ๐Ÿ‡ง UK